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The many faces of epidemiology: evolutionary epidemiology
As muitas faces da epidemiologia: epidemiologia evolucionária
Resumo  Apresentamos os principais conceitos re-
lacionados à aplicação da teoria evolutiva a pro-
blemas epidemiológicos. Limitamo-nos às doenças
infecciosas e à evolução da virulência como conse-
qüência das estratégias de controle da transmissão
em saúde pública. Nosso foco é voltado à  discussão
sobre a possibilidade de controle da virulência e
exploramos possíveis cenários atuais em que os
avanços recentes em biologia molecular e genética
oferecem novas ferramentas de controle e monito-
ramento de variações na diversidade em patóge-
nos e hospedeiros. Chamamos a atenção para a
necessidade de integrar a estrutura analítica da
epidemiologia com a genética de populações e a
teoria evolutiva. Seguindo a tradição epidemioló-
gica, antecipamos como resultado deste processo o
desenvolvimento de desenhos de estudos e ferra-
mentas analíticas de predição das implicações evo-
lutivas das medidas de controle usadas em popula-
ções e mecanismos de vigilância que permitam o
monitoramento contínuo de mudanças nos pa-
drões de virulência de patógenos. A comunicação
entre modeladores, epidemiologistas e biologistas
moleculares torna-se essencial ao desenho de en-
saios de campo motivados por dados empíricos e
ao desenvolvimento de ferramentas analíticas que
possam informar o processo de decisão orientado
aos problemas em saúde pública.
Palavras-chave  Epidemiologia evolutiva, Doen-
ças infecciosas, Controle da virulência, Biologia
molecular, Genética de populações
Abstract  We review important issues revealed by
the application of the evolutionary theory to epi-
demiological problems. The scope is restricted to
infectious diseases and the evolution of virulence
as a consequence of public health strategies to con-
trol transmission.  We focus on the discussion about
the possibility of virulence management and ex-
plore current scenarios in which recent advances
in molecular biology and genetics offer new tools
to monitor and change diversity among patho-
gens, vertebrate and invertebrate hosts. We stress
the need to integrate the analytical framework of
epidemiology into population genetics and evolu-
tionary theory. We anticipate as an outcome of
this process the development of study designs and
analytical tools to predict the evolutionary impli-
cations of control measures in the population and
surveillance mechanisms to continuously moni-
tor the changes in pathogen virulence patterns.
Communication among modelers, epidemiologists
and molecular biologists is essential in order to
design model-driven field trials and to develop
data-driven analytical tools leading to conclusive
findings that can inform the public health orient-
ed decision making process.
Key words  Evolutionary epidemiology, Infectious
diseases, Virulence management, Molecular biol-
ogy, Population genetics
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Introduction
Evolutionary concepts have been influencing the
thinking in the health sciences for quite some time
now1. The contributions range from noninfec-
tious and degenerative diseases2 to infectious dis-
eases and public health3 and provide insights into
fields such as prescribing antibiotics, planning
the control of virulent diseases through vaccina-
tion and/or mass drug administration, offering
genetic advice to family planning, and treating
chronic conditions such as diabetes, high blood
pressure, cancer, asthma, allergic reactions, and
obesity. Two new disciplines have emerged from
the research activities in this area: Darwinian
medicine4  and evolutionary epidemiology5,6.
The most obvious examples of evolution in
action in a medical setting are perhaps the devel-
opment of resistance following the use of drugs
against pathogens (such as antibiotics, antiret-
rovirals, or antimalarials) or rsistance following
the use of insecticides against disease vectors7.
Well documented additional examples are the co-
evolution8 of the human host resistance to ma-
laria driven by genetic selection of the sickle cell
trait9,10 and the CCR5-Delta32 deletion allele im-
plicated in the mechanisms of resistance against
HIV-1, bubonic plague and smallpox11,12.  Also,
the debate about the obligate evolution of the
host-pathogen interaction towards commensal-
ism represents a classic contribution to the foun-
dations of this new discipline5.
Examples that compose the current research
agenda of investigators in the field of evolution-
ary epidemiology include the impact of vaccina-
tion on the evolution of parasite virulence13, the
emergence of new infectious diseases14 and whole-
genome analysis15 of pathogen16  and vector17,18
evolution. This research agenda is influenced by
recent advances in molecular biology and genet-
ics that provide new tools to monitor the diversi-
ty among pathogens, vertebrate and invertebrate
hosts19-21 .
Public health measures to control infectious
diseases have relied on the use of vaccines, insec-
ticides and the various types of drugs and, un-
derstandingly, most of the literature cited above
addresses the evolutionary implications of such
control measures. New control strategies based
on the genetic manipulation of pathogens and
vectors, made possible by current advances in
molecular genetics and mosquito ecology22, also
holds a promising future and could act synergis-
tically to current control strategies. Genetic meth-
ods for controlling vector transmission are de-
signed to reduce or eliminate vector populations,
to selectively kill only those vectors infected by
the pathogen, or to modify (replace) natural vec-
tor populations by introgressing genes that elim-
inate vector competence. Mechanisms of action
of transgenes display route of entrance and tis-
sue specificities in vectors and can, therefore, lead
to distinct qualitative dynamics.  These methods
are at various stages of development and readi-
ness for field-testing. The evolutionary impact of
different transgenic mosquito strategies is an
important component in the discussion of bene-
fits, risks, and research priorities associated with
using genetically manipulated insects in the con-
trol of vector-borne diseases23,24.
In this review, we intend to introduce the ba-
sic principles of evolutionary epidemiology. We
use examples of significant evolutionary insights
drawn from the emerging activities on the new
strategies to control vectors of parasitic and viral
diseases of importance for public health. Al-
though we are dealing with a broad subject our
approach serves two main objectives. First we
hope to introduce social scientists to the main
questions at the interface between evolution and
epidemiology. Second we intend to complement
the vast literature on the subject by reviewing the
main contributions to the field of vector-borne
diseases having in mind the new disease control
actions being proposed.
Basic principles
This review is written under the assumption that
evolutionary thinking may contribute towards
the alleviation of human health problems. For
example, understanding the evolution of para-
site virulence and drug resistance it might be pos-
sible to design better vaccines, prevent the emer-
gence of highly virulent strains possibly induced
by current public health practices, diminish the
virulence of present pathogens, and improve the
use of antimicrobials. The proposed framework
to explain how natural selection has shaped hu-
mans and shaped the parasitic organisms with
which humans interact is based on a trade-off
model between transmission and virulence in
which the following premises hold: parasite-
caused host mortality is costly for the parasite
and transmission and virulence are correlated.
We visit next the main elements that shape the
definition of reproductive success and virulence,
two basic concepts that are central to this view.
1745
C
iência &
 Saúde C
oletiva, 13(6):1743-1752, 2008
Reproductive success
The most basic evolutionary process we are
dealing with is natural selection.  It is important
to stress the level at which this process acts. Nat-
ural selection favors individual traits that increase
the passing on of the genes that code for the traits.
Therefore, there is no reason to presume that
natural selection favors what is best for the spe-
cies or for the greatest number of individuals over
the greatest amount of time. This latter concept
(that selection could act at the species level) led to
a widespread misunderstanding in the past, i.e.,
the idea that parasites should evolve toward be-
nign coexistence with their hosts. Parasitic strat-
egies that lead to higher replication rates and, in
this way, to a greater presence of the genes coding
for this strategy in the next generation of individ-
uals, will prevail over competing strategies, no
matter their impact on the parasite host. The rel-
evant concept here is the number of genes passed
onto the succeeding generation3.
Reproductive success can be measured by the
basic reproductive number (R
0
). It is a measure
that summarizes the tradeoffs involving all di-
mensions that contribute to the dynamics of a
particular population of interest. It describes the
number of individuals in a subsequent genera-
tion that originates from one particular individ-
ual. In the context of infectious diseases,  describes
the number of secondary cases generated by the
index case in an otherwise uninfected host popu-
lation. In general, eradication of an infectious dis-
ease becomes possible when the control measures
available are successful in reducing R
0 
to R
0 
< 1.
Probably, malaria offers one of the most im-
portant examples of the application of the con-
cept of   which, in this case, is given by the expres-
sion
The following notation applies: m mosquito
density,  a biting rate and ma number of mosqui-
toes that bite an infective human host per day,  b
proportion of daily mosquito bites that are infec-
tive to mosquitoes,  pn  mosquito survival proba-
bility beyond day n (extrinsic incubation cycle)
after infection, c proportion of daily mosquito
bites that are infective to humans,  r human re-
covery rate,  - ln (p)  expected survival time once
the extrinsic incubation cycle has been completed.
This expression reflects the contribution of the
entomological and human component to disease
transmission and explains the rationale for vari-
ous control measures still in place nowadays. For
example, the use of larvicides or elimination of
breeding sites of the vector affect R
0
 linearly
through the parameter m. On the other hand, the
use of insecticides that kill adult mosquitoes affect
R
0
 exponentially through the parameter p, the
probability of daily survival. For an heuristic in-
troduction to this expression see Ribeiro &
Struchiner25 and for a formal definition of R
0
 see
Diekmann & Heesterbeek26. A historical account
of the evolution of the concept of  R
0
 in the vari-
ous disciplines and the description of a procedure
for its calculation can be found  in Heesterbeek27.
Given the virtues of R
0
 as a measure of effec-
tive transmissibility, the traditional approach of
predicting evolutionary outcomes has relied on
the maximization of this quantity. The criterion
for the success or failure of a pathogen strain
that differs in aggressiveness from a resident strain
is its rate of spread through a given host popula-
tion. Under the approach of maximizing a patho-
gen’s transmissibility, if the new pathogen spreads
faster than its predecessor does, i.e., if its R
0
 is
higher that its predecessor’s, than it may invade
and replace that predecessor resident pathogen.
It is easily shown that the transmissibility of a
pathogen can be the highest at intermediate levels
of virulence and, therefore, a more aggressive
pathogen strain might invade and displace a more
benign resident strain. This behavior explains why
pathogens and their hosts do not always evolve
in ways that would render benign the consequenc-
es of infection and explains stable patterns of in-
termediate levels of virulence mediating the patho-
gen–host interaction. However, R
0
 does not tell
us the full story as we shall see next Dieckmann28.
The limitations of the approach based on  R
0
maximization are due to: (i) R
0
 describes the per-
formance of a strain in an environment of unin-
fected hosts only and does not describe the ca-
pacity of that strain to displace a different strain
already infecting the host population; (ii) an op-
timization principle describing the quantity to be
maximized by evolution might not exist as is the
case of the of frequency-dependent selection, when
selective pressures and the resultant invasion suc-
cess depend on the composition of the resident
pathogen population; (iii) a static optimization
principle based on R
0
 assumes that pathogens
often have much shorter generation times than
their hosts and may be expected to experience
essentially a non-evolving host population in the
course of their adaptation and, therefore, cannot
account for the adaptation of pathogen–host
interactions in terms of complex co-evolution-
ary dynamics; (iv) usually adaptation can only
explore the small range of variation that is acces-
ma2bpn
- ln (p)         r
R
0 =
x  c  .
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sible by gradual change and  some evolutionary
outcomes predicted by the analysis of evolution-
ary stability alone, such as the optimization prin-
ciple based on the maximization of R
0
, actually
cannot be reached by a sequence of small adap-
tive steps.
Given the limitations of the conventional ap-
proach to maximize R
0
, an extended framework
to describe the complex processes that arise from
the evolution of general pathogen–host interac-
tions becomes necessary. The alternative ap-
proach of adaptive dynamics28 addresses the chal-
lenges listed in the previous paragraph. This ap-
proach takes into account that the fitness of a
phenotype can only be evaluated relative to the
environment that this phenotype experiences, and
identifies four invasibility patterns. Under evolu-
tionary stability a singular phenotype is immune
to invasions by neighboring phenotypes. This
concept is a local version of the classic evolution-
arily stable strategy (ESS) condition that arises in
evolutionary game theory. ESS is an equilibrium
condition which is “evolutionarily” stable, mean-
ing that once it is fixed in a population natural
selection alone is sufficient to prevent alternative
(mutant) strategies from successfully invading.
Theory indicates that, contrary to what might
be expected, a population does not always evolve
toward an evolutionarily stable state. Evolution
can lead away from an ESS and, in this case, we
say that the ESS is evolutionarily unattainable or
convergence unstable. Convergence stability is
attained when invaders starting from neighbor-
ing phenotypes in relation to the resident strain
do succeed and lie closer to the singular pheno-
type29. Under this condition, any mutant allele of
small effect can invade the resident population,
but the mutant allele cannot entirely displace the
resident allele and some form of evolutionary
diversification occurs.
Mutual invasibility implies that if a pair of
neighboring phenotypes lies either side of a sin-
gular phenotype they can invade each other. Co-
existence of phenotypes and the emergence of
polymorphisms arise as a possibility when this
condition is met. The characterization of an evo-
lutionary endpoint also benefits from a discus-
sion of the invasion potential of a singular phe-
notype towards its neighboring types.
Virulence
It is not easy to define virulence both at a
molecular level and at the level of the population.
For population biologists, virulence is the in-
creased host mortality resulting from parasite
infection30.  This definition makes clear that viru-
lence has an unambiguous negative impact on
the fitness of most parasites since, for many life
cycle patterns, death of the host halts further
transmission of the parasite. As expected, this
definition does not please everyone since it ig-
nores many dimensions present in parasite-host
relations that harm the host and may rightly be
considered virulence30.
Virulence varies between strains of most
pathogenic parasites suggesting the plausibility
of being the outcome of evolutionary processes.
However, high virulence can exist without any
apparent evolutionary history in a host, as is the
case of zoonotic diseases in which humans are
not the natural host, e.g., yellow fever and other
hemorrhagic fevers, hantavirus and arenavirus
infections, viral encephalitis, and tick fevers. The
trade-off model, in particular, requires a defini-
tion of virulence based on traits contributing to
parasite fitness and thus being under the action
of evolution. Although it is possible to trace an
evolutionary component leading to virulence di-
versity, there are examples in which virulence has
little to do with transmission and where inter-
vention resulted in a change of virulence that was
inconsistent with the classic trade-off model31.
The diversity of multistage life cycles of vari-
ous tropical parasites points to additional aspects
of the host-parasite interaction which might also
mediate parasite fitness, such as the host immune
response, and the time course and tissue tropisms
of infection. Therefore, a more realistic view of
trade-offs should include not only host mortali-
ty, but also factors potentially associated with
parasite evolution as an outcome of within-host
and between-host competition among parasite
strains. Factors that have entered the theoretical
studies so far suggest that the virulence optimum
is sensitive to the abundance of susceptible hosts,
the intrinsic host lifespan, the rate of clearance of
the infection by the host’s immune system, the
size of the inoculum, the route of inoculation, the
frequency of naturally occurring infections, met-
abolic costs, modes of transmission (horizona-
tally, vertically, vectorborne airborne- or sexual-
ly), pathogen genotype variation, antimicrobial
dose dependence, host nutrition, age at first ex-
posure, interactions with other infectious diseas-
es or parasite species, the mode of action of the
transmission control measure (infection block-
ing, transmission blocking, disease modifying, and
anti-toxin), and specificities of pathogenesis (par-
asites that must kill their hosts to effect trans-
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mission, parasites that castrate or sterilize their
hosts, parasites that are virulent by means of tox-
ins). The main message that emerges from this
large body of empirical evidence is that one can-
not validate the trade-off model in natural con-
ditions because of the large number of unmea-
sured variables31.
The reason why parasites harm their hosts if
a live and healthy host is beneficial to their trans-
mission has been extensively debated in the liter-
ature, as we have pointed out. There are several
difficulties with empirical applications of the
trade-off model. Virulence management is based
on the idea that changes in opportunities for par-
asite transmission will select for changes in viru-
lence. If the correlation between transmission and
virulence is low and the response to selection slow,
management cannot be achieved in a timescale
appropriate for guiding public health actions.
Also, virulence is not always a simple function of
parasite reproduction. For observing a virulence
optimum as an outcome of a trade-off mecha-
nism, virulence has to increase more rapidly than
transmission rate.  This condition for the exist-
ence of a virulence optimum has not been sup-
ported with empirical data. The literature does
not support either the view that many infectious
agents have evolved new levels of virulence in re-
cent years.  The use of vaccines and antimicrobi-
als, and modern hygiene standards should have
selected large changes in virulence if the theory
was correct. Experiments conceived to reveal the
causes of evolution of virulence and to test pre-
dictions of the trade-off model need to incorpo-
rate sufficient biology and control for long term
trends (e.g. nutritional, behavioral, and environ-
mental) that could confound the observed chang-
es in virulence31.
Current scenarios
Recent advances in molecular biology and genet-
ics provide new tools to monitor diversity among
pathogens, vertebrate and invertebrate hosts. The
genetic manipulation of pathogens and vectors
also holds a promising future. We briefly review
some of the current main research issues brought
by these new technologies and exemplify the ap-
plication of the evolutionary paradigm intro-
duced above to this new scenario.
Molecular biology and epidemiology
Following the birth of molecular biology a
new paradigm was introduced in the epidemio-
logic literature in the early 80s. It had an impact
in uncovering new sources of heterogeneities and
illustrates the importance of taking into account
the biological details of the interaction between
the pathogen, the vector and the vertebrate hosts.
Under this paradigm, the design of control strat-
egies against endemic diseases started to explain
the mechanism of action of the intervention it-
self. The three main mechanisms considered were
infection blocking, disease (morbidity) modifi-
cation, and transmission blocking. The discrim-
ination among the three mechanisms was moti-
vated by the early attempts to develop a malaria
vaccine. In this context, the search for potential
target epitopes for a vaccine was explicitly associ-
ated with different stages of the parasite (sporo-
zoite, merozoite, and gamete), each stage corre-
sponding to a mechanism of action32.
Mechanism-specific models have shown to
be useful to uncover the complex implications of
intervention programs against mosquito-borne
diseases. Halloran et al.33 focused on the changes
in immune profile of the target population. Gan-
don et al.34 relate the mechanism of action of a
vaccine to the evolution of pathogen virulence.
These authors show that leaky vaccines designed
to reduce pathogen growth rate (disease modify-
ing) can lead to higher levels of virulence that
translates into more severe morbidity among the
unvaccinated individuals. Based on these prelim-
inary findings, it becomes necessary to further
investigate the evolutionary impact implied by
the use of antiretrovirals that lower virus load
among HIV infected individuals or, for that mat-
ter, the development of vaccines that modify the
course of infection caused by HIV. The epidemi-
ological and biostatistical literature that followed
clearly acknowledges this distinction and its im-
plications. In particular, new definitions of vac-
cine efficacy have been proposed35-37.
Heterogeneity uncovered
Virulence is not a fixed property of infection
but is affected by the genetic diversity of the play-
ers involved, i.e., the vertebrate and invertebrate
hosts, the pathogen and the environmental con-
ditions under which those players interact38.
Above, we introduced  as a measure of repro-
ductive success and offered a very simple expres-
sion that illustrates its use in malaria. The pa-
rameters that entered that expression can be bro-
ken down into a multitude of new parameters
accounting for known additional details, each
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assuming a stochastic distribution that better
describes individual heterogeneities.
For example, the anatomical structures that
serve as developmental sites for the various stag-
es of a pathogen in a mosquito vector include the
salivary glands, the midgut, the hemolymph and
hemocoel, the peritrophic matrix, the distal cells
of the Malpighian tubules, and the thoracic mus-
culature. All these pathogen-tissue encounters
within the mosquito vector represent new op-
portunities for vector immune responses to
pathogen invasion. The biological mechanisms
that mediate the vector susceptibility to the patho-
gen and interfere with the reproductive success
of a parasite in the vector include melanotic en-
capsulation, phagocytosis and production of
antibacterial compounds and immune peptides.
Together, they represent candidate pathways
through which virulence could be under the in-
fluence of natural selection39.
Blood-feeding arthropods require the unim-
peded flow of blood from host organisms. Anti-
hemostatic factors present in the mosquito saliva
allow these insects to blood feed efficiently. Im-
proper functioning of these antihemostatistic fac-
tors represents a potential barrier to pathogen
development since it leads to coagulation of blood
within the midgut and can inhibit ingested patho-
gens from migrating out of this environment as is
required for further development. This potential
barrier to pathogen development could become
the target of potential control strategies and adds
to the complex mechanisms that set the stage for
strong selection pressure on pathogens. The bio-
chemical makeup of the ingested blood contain-
ing the pathogen affects the parameters that enter
the  expression, such as, the mosquito biting rate,
its mortality, and the developmental period of the
parasite within the mosquito.
Regarding the heterogeneity of the parasite,
the concept of quasispecies is particularly impor-
tant in this context and applicable to the evolu-
tion of pathogens that generate high level of ge-
netic variation, such as the RNA viruses. This
concept describes the final distributions of clouds
of genotypes subject to mutation-selection bal-
ance and that evolved to a stable state40. The con-
cept offers a novel evolutionary dynamics insight
that explains the phase transition in the compo-
sition of genotypes in populations as modulated
by changes in mutation rate. The theory of qua-
sispecies motivated an important medical appli-
cation, the extinction of RNA virus populations
by lethal mutagenesis achieved by the use of the
antiviral drug ribavirin. This drug contains base
analogs that are incorporated into the viral ge-
nome elevating mutation rates to the point that
the virus population disappears.
Whole genome studies
The availability of the genome sequences of
vectors, hosts and parasites has enabled genome
wide comparative studies. Of particular interest
are the studies comparing the insect immune rep-
ertoire, the means whereby those insects are able
to kill invading pathogens. Knowledge about the
genes controlling the susceptibility of the vector
to the pathogen helps in understanding the mech-
anisms that mediate parasite development, from
the time the pathogen is ingested in a blood meal
until the infective stage of the pathogen is trans-
mitted to the vertebrate host. This knowledge is
crucial in developing new technologies of vector
control by interfering with normal pathogen de-
velopment within the vector41.
Large-scale bioinformatic methods, manual
curation, and phylogenetic analyses of the avail-
able genomes turn it possible to identify immune
signaling pathways and response modules in in-
sect vectors.  Nine sequenced genomes from four
holometabolous insect orders, spanning 350 mil-
lion years of evolution are the subject of attention
and include the yellow fever and dengue vector,
Aedes aegypti, the malaria vector Anopheles gam-
biae, and the fruit fly Drosophila melanogaster. This
approach explores important evolutionary dif-
ferences among the species. The two mosquito
species diverged ~150 million years ago and the
fly separated from them ~250 million years ago.
Hematophagy to sustain abundant progeny pro-
duction in mosquitoes provided a new point of
entry for pathogens an aspect sharply contrast-
ing with the fruit fly reproductive strategies18.
Using a comparative phylogenomic analysis
of the insect immune repertoire, the gene families
and functional groups implicated in classical in-
nate immunity or defense functions, such as ap-
optosis and response to oxidative stress, recapit-
ulate the evolutionary steps leading to the diver-
gence or conservation of the gene subsets. These
modes of immune evolution are linked to the
modes of action of the immune mechanisms,
such as recognition of parasite invasion and neu-
tralization of the microbial source of the immune
signal. Mechanisms acting directly on microbes
diversify rapidly or are species-specific. These
mechanisms suggest co-evolution with pathogens
and can be evaded by them. On the other hand,
effector enzymes that produce chemical cues to
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attack invaders remain conserved probably as the
outcome of strong selective pressure18.
New interventions
Several new intervention strategies against
mosquito-borne diseases are being proposed.
Their own novel mechanism of action explores
the sensitivity of the dynamics of mosquito-
borne diseases to genetic heterogeneities at the
various stages of the parasite life cycle in the vec-
tor and in vertebrate hosts, as shown above. Ge-
netic methods for controlling vector transmis-
sion are designed to reduce or eliminate vector
populations, to selectively kill only those vectors
infected by the pathogen, or to modify (replace)
natural vector populations by introgressing genes
that eliminate vector competence. Innovative con-
trol strategies based on transgenesis of mosqui-
to vectors offers potentially smaller ecological and
environmental impact than control strategies that
rely heavily on mosquito control using insecti-
cides, which are susceptible to the emergence of
insecticide-resistant mosquito populations24, 42.
Mechanisms of action of transgenes display
route of entrance and tissue specificities in vec-
tors and can, therefore, lead to distinct qualita-
tive dynamics. They can be grouped as: strategies
that block transmission, either from humans to
mosquitoes or from mosquitoes to humans; re-
duce mosquito biting by interfering with the host-
seeking behavior, perhaps only after the first blood
meal or, only upon infection; raise mosquito back-
ground mortality through the release of engi-
neered males homozygous for a dominant fe-
male-killing gene (elimination of female off-
spring); or raise mosquito infection-induced
mortality, i.e., lethal genes only expressed in the
presence of infection in mosquitoes.
These methods are at various stages in their
development and readiness for field-testing. De-
spite the promise of these new control strategies,
these interventions select for changes in pathogen
virulence to both the human and mosquito hosts
and their evolutionary impact remains to be ex-
plored. Under this framework, the trade-offs of
importance should entertain the definition of vir-
ulence and fitness costs in both hosts as well as
the pathogen simultaneously. It is possible to spec-
ulate that transgenic strategies based on blocking
transmission or reducing mosquito biting could
select for increased virulence to humans while strat-
egies that increase mosquito background or in-
fection-induced mortality do not select for changes
in virulence to humans. However, it is also plausi-
ble to suppose that whether selection is to increase
or decrease virulence is sensitive to the specific
choices of trade-off between virulence and other
epidemiological traits.
Study design
The formalism of epidemiologic methods,
which has proved useful in identifying risk fac-
tors in chronic and infectious diseases as well,
still requires further developments in order to
guide the design of field studies to address key
questions in evolutionary epidemiology. Of great
need are epidemiologic and surveillance methods
that could identify and monitor changes in patho-
gen virulence due to public health practices such
as vaccination and large scale use of antivirals.  In
this context, the usual definitions of efficacy and
effectiveness will need to follow a new paradigm
and also address the evolutionary dimensions
involved. The challenges ahead cannot be under-
estimated. It will be necessary to develop analyt-
ical models and sampling procedures that could
accommodate the various levels of observation
(from the molecular to the population levels),
hierarchical correlation patterns (within and be-
tween hosts, within and between households and
villages, within and between races), and conceive
new measures of association motivated by ana-
lytical tools borrowed from other disciplines such
as population genetics and phylogenetics32.
Many ecological and evolutionary conse-
quences of long term disease control measures in
populations will become obvious only on time
scales longer than those of field trials required to
license new vaccines, antimicrobials or genetical-
ly modified disease vectors. It is expected that
large-scale use of any of those disease control
strategies will alter the number and virulence of
pathogen genotypes, either by reducing the force
of infection or by directly altering the population
dynamics of subsets of the circulating genotypes.
Therefore, the licensing of new intervention tools
as well as the surveillance of new and current
strategies already in use must take into account
the impact of control strategies on the evolution
of virulence in pathogens. Analogously to cur-
rent vaccine trials that provide the necessary em-
pirical background to assess the efficacy of a vac-
cine, informed public health decisions in this area
must rely on study designs, sampling mecha-
nisms and epidemiologic parameters specifically
conceived with this end in mind and yet to be
developed. Of great importance are surveillance
methods that could inform the decision making
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ahead of time, much before the appearance of
virulent strains becomes a reality.
Discussion
In this work, we briefly reviewed important issues
revealed by the application of evolutionary theo-
ry to epidemiological problems. The scope of our
work is restricted to infectious diseases and the
evolution of virulence as a consequence of public
health strategies to control transmission.  We fo-
cused on the discussion about the possibility of
virulence management and explored current sce-
narios in which recent advances in molecular bi-
ology and genetics provide new tools to monitor
and change diversity among pathogens, vertebrate
and invertebrate hosts. Vaccine-driven evolution
of pathogen virulence, either by selectively acting
against a subset of the antigenically diverse popu-
lation of pathogens, or evolutionary changes on
pathogen traits related to transmissibility allow-
ing for immune evasion, is a related area that is
receiving considerable attention more recently.
The need to integrate the analytical frame-
work of epidemiology into population genetics,
and evolutionary theory seems of paramount
importance. This unified framework of analysis
holds the promises of simultaneously address-
ing modern emerging theories at the interface of
these disciplines. Following the epidemiological
tradition, we anticipate as an outcome of this
process the development of study designs and
analytical tools to predict the evolutionary im-
plications of control measures in the population
and surveillance mechanisms to continuously
monitor the changes in pathogen virulence pat-
terns. Precise definition of biological concepts,
such as virulence and reproductive success, and
the development of formal causal pathways are
essential to keep complexity to a minimum and
allow for comparability of model outcomes.
Communication among modelers, epidemiolo-
gists and molecular biologists is essential in or-
der to design model-driven field trials and to de-
velop data-drive analytical tools leading to con-
clusive findings that can inform the public health
oriented decision making process.
The evolutionary impact of transmission con-
trol through the genetic manipulation of vector
competence will be difficult to assess given the
multidimensional nature of the outcome. For ex-
ample, mechanisms that render the vector resis-
tant to the pathogen and that have as the site of
action the salivary gland, not only interfere with
the natural development of the pathogen, but also
with the biting properties of the vector. The mech-
anisms of action involved can operate at different
developmental stages of the pathogen and in dif-
ferent tissue sites within the mosquito. However,
this is not the full story since transmission con-
trol strategies based on genetically modified or-
ganisms will possibly be used in conjunction with
current and future methods, i.e., insecticides, bio-
logical control of mosquito larvae, antimicrobi-
als, vaccines, genetic manipulation of the parasite,
human behavior modification, etc. It is up to this
new discipline to face the challenge and indicate
the ways in which pathogen virulence could be
managed in this context.
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